Currency: CHF
Period
FY2023 Annual Report
Apr 10, 2024
0.00
-7.88
No Data
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency:
Altamira Therapeutics | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Apr 23 10:18
Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Apr 17 05:01
Apr 10 20:32
Altamira Therapeutics | 20-F: Registration statement / Annual report / Transition report
Apr 10 20:02
Read more